Company intelligence / Profile preview

Caremitou

Ownership: Private
Development stage: Commercial

Overview

Caremitou has developed a clinically validated, CE-certified smart litter box that collects vital data to facilitate early detection of cat health problems. The device is commercially available since 2022 and has won innovation awards at CES Las Vegas in the Health and Wellness category. The product's clinical validation supports its utility as an early warning system for feline diseases by tracking weight changes and behavior patterns.

Therapeutic areas: OtherMetabolic Disorders
Modalities: Device
Industry: Veterinary

Partnerships

No major pharmaceutical or biotech partnerships disclosed; collaboration with veterinary experts mentioned

Beyond the preview

Go deeper on Caremitou.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caremitou.

Explore the full profile